Name
Michael Zandi
CoPED ID
2fa60707-f70d-41c7-9762-179c9069f60f
None
OrcidID
0000-0002-9612-9401
LinkedIn URL
Projects in CoPED
A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2)
Status: Active
Total funding: £4,939,666
From: July 31, 2016
To: March 31, 2024
Organisations: 3
People: 5
Organisations
Links
Added to CoPED
April 11, 2022, 1:37 a.m.
Last update
Nov. 27, 2023, 1:20 p.m.